Yunnan Cancer Hospital — Kunming

Public research footprint of Yunnan Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

197

Registered studies

124

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Breast Cancer · Pancreatic Ductal Adenocarcinoma (PDAC) · Advanced Hepatocellular Carcinoma (HCC)

Recently updated registry entries

NCT06596473 — A Study of BG-C477 in Participants With Advanced Solid Tumors (Recruiting)
NCT07276399 — A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC… (Recruiting)
NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Yunnan Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.